US STOCKS-Futures bounce after tech rout sends Nasdaq into correction
Nasdaq futures bounced on Wednesday following a brutal sell-off in heavyweight technology stocks that sent the Nasdaq Composite index into correction territory in just three sessions.
- Country:
- United States
Nasdaq futures bounced on Wednesday following a brutal sell-off in heavyweight technology stocks that sent the Nasdaq Composite index into correction territory in just three sessions. The tech-heavy stock index tumbled 4.1% on Tuesday, bringing total losses since Sept. 2 to 10%, with declines led by stocks such as Amazon.com Inc, Facebook Inc and Netflix Inc after a rally dominated by the so-called "stay-at-home" winners.
Investors were also unnerved by heavy trades in tech stock call options by SoftBank Group Corp during the run up in U.S. equities. A measure of demand for protective put options in relation to call options, used to bet on upside, has risen sharply. Tesla Inc surged 7% in premarket trading after shedding about $80 billion of its market capitalization in the previous session following its surprise exclusion from the S&P 500.
At 5:37 a.m. ET, Nasdaq 100 e-minis were up 196 points, or 1.77%, Dow e-minis were up 140 points, or 0.51%, and S&P 500 e-minis were up 25.75 points, or 0.77%. Wall Street's fear gauge slipped further away from near three-month highs as stock markets also shrugged off news about AstraZeneca pausing global trials of its experimental COVID-19 vaccine after an unexplained illness in a participant.
Lululemon Athletica Inc dropped 4.9% after the yogawear maker forecast a drop in current-quarter adjusted profit due to higher marketing expenses.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Tesla Inc
- AstraZeneca
- Nasdaq
- SoftBank Group Corp
- S&P
- COVID
- COVID-19
ALSO READ
US STOCKS-S&P 500, Nasdaq close slightly higher after soft services sector data, Fed comments
US STOCKS-S&P 500, Nasdaq close slightly up after soft services sector data; Fed comments
Health News Roundup: AstraZeneca's Imfinzi shows promise in treating aggressive lung cancer; US FDA issues warning letters to retailers against underage sale of ZYN nicotine pouches and more
BRIEF-AstraZeneca Says Imfinzi Improved OS & PFS In Limited-Stage SCLC
US STOCKS-S&P 500, Nasdaq choppy as higher bond yields weigh